| Friday November 18, 2016 |
| 08:00 | Registration |
|
| 08:50 | Opening |
Dr Laurent PROVINS
(UCB, Braine-l'Alleud, Belgium) |
| 09:00 | PL01 - PET Tracer Development and Translation to the Clinic |
Prof Guy BORMANS
(KULEUVEN, Leuven, Belgium) |
| 09:50 | PL02 - PET Chemistry: Routine Application, Recent Advances and Ongoing Challenges |
Dr Jan PASSCHIER
(IMANOVA, London, United Kingdom) |
| 10:40 | Coffee Break & Exhibition |
|
| 11:15 | OC01 - Late-Stage Fluorination for PET Imaging |
Prof. Tobias RITTER
(MAX-PLANCK-INSTITUT FÜR KOHLENFORSCHUNG, Mulheim, Germany) |
| 11:45 | PL03 - Clinical Imaging Agents, and the Art of Medicinal Chemistry |
Dr Yves P. AUBERSON
(NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland) |
| 12:35 | Lunch, Exhibition & Poster Session I |
|
| 14:00 | PL04 - SV2A Imaging and the Potential Applications in Neurodegenerative Disorders |
Prof. Eric SALMON
(ULG, Belgium) |
| 14:50 | OC02 - Synthesis and in vivo PET Evaluation of a 18F Bile Acid to Assess Drug-Induced Liver Injury in Mice |
Mr Stef DE LOMBAERDE
(GHENT UNIVERSITY, Gent, Belgium) |
| 15:10 | OC03 - in vivo Evaluation of Novel 18F-Labeled TCO Analogues for Pretargeted Immuno-PET Imaging in a HER2 Positive Cancer Model |
Mr Jens FISSERS
(UNIVERSITY OF ANTWERP, Antwerpen, Belgium) |
| 15:30 | Coffee Break, Exhibition & Poster Session II |
|
| 16:05 | PL05 - Antibody Imaging and Therapy Using in Vivo Click and Click-to-Release Strategies |
Dr Marc ROBILLARD
(TAGWORKS PHARMACEUTICALS, Eindhoven, The Netherlands) |
| 16:55 | PL06 - The Value of PET Ligand Discovery to CNS Drug Development |
Dr Mark SCHMIDT
(JANSSEN PHARMACEUTICA, Beerse, Belgium) |
| 17:45 | Closing Remarks |
Prof. Koen AUGUSTYNS
(UNIVERSITY OF ANTWERP, Antwerp, Belgium) |
